Company
Headquarters: Tokyo, Japan
Employees: 342
¥6.27 Billion
JPY as of Jan. 1, 2026
US$40.0 Million
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $37.81 B |
| Veeva Systems Inc. | $36.08 B |
| M3, Inc. | $11.14 B |
| Change Healthcare Inc. | $9.03 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
WDB coco Co., Ltd. operates as a contracted drug development company. It supports the development of pharmaceuticals and medical devices with a focus on safety information management. The company was founded in 1984 and is headquartered in Tokyo, Japan.
WDB coco Co. Ltd has the following listings and related stock indices.
Stock: JPX: 7079